UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Theodore Moore, MD

Print
Email

Theodore Bruce Moore, MD

UCLA Physician Theodore  Bruce  Moore, MD specializes in Pediatric Hematology-Oncology.
Specialty
Pediatric Hematology-Oncology
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
G69308
Contact
(310) 825-0867 Appointments and referrals
(310) 825-6708 for information
Fax Number
(310) 206-8089
Voted Best Doctor
Voted Super Doctor
PRACTICE LOCATION
UCLA Children's Health Center
200 UCLA Medical Plaza, Suite 265
Los Angeles, CA 90095
MEDICAL BOARD CERTIFICATION
Pediatric Hematology-Oncology, American Board of Pediatrics, 1998, 2013
EDUCATION
Fellowship
Pediatric Hematology-Oncology, UCLA School of Medicine, 1992 - 1995
Residency
Pediatrics, UCLA School of Medicine, 1990 - 1992
Internship
Pediatrics, UCLA School of Medicine, 1989 - 1990
Medical Degree
MD, Oregon Health Sciences University School of Med, 1989
AFFILIATION
IN THE NEWS
MORE INFORMATION
Research Interest
Dr. Moore's areas of research interest are in Pediatric Hematopoietic Stem Cell Transplant, relapsed leukemia, and infections in the immunocompromised patient.
Additional Information
Theodore B. Moore, M.D is Professor of Pediatrics, Chief of Pediatric Hematology/Oncology and Director of the Pediatric Blood and Marrow Transplant Program at UCLA.

He trained in Pediatric Hematology/Oncology here at UCLA from 1992-1995, serving as a Clinical Instructor from 1994-thru 1996. He then took the position of Director of Pediatric Stem Cell Transplant at the Oregon Health and Science University in Portland, Oregon building the Pediatric Hematopoietic Stem Cell Transplant program there from its infancy.

He returned to UCLA joining the UCLA School of Medicine faculty in 2001 with his current appointment in the Division of Pediatric Hematology/Oncology in the Department of Pediatrics. He is active in Clinical Research serving as the UCLA Prinicpal Investigator of the Pediatric Blood and Marrow Transplant Consortium and the Primary Immune Deficiency Treatment Consortium.

Dr. Moore currently serves on several committees within the hospital. He serves as Chair of Sub-Committee B of the medical school admissions committee, a member of the hospital cancer committee and is current President of the Executive Board of the Department of Pediatrics Group Practice Plan. He also serves as a member the Board of UCLA Health's Faculty Practice Group.

His outside interest is international medicine and is actively involved in international education and international relief efforts.

Awards & Recognition
  • Outstanding Physician, UCLA, 2013
  • SuperDoctors, top 5% of doctors in Southern California, 2008-2013
  • Guide to America’s Top Oncologists, Consumer Research Council of America, 2007-2013
  • Best Doctors in America, selected by peer review survey, medical experience and certification, 2007-2013
Publications
  1. Morimoto K, Moore TB, Schiller GJ, Sakamoto KM. Transplantation in Congenital Bone Marrow Failure Syndromes. Bone Marrow Research, vol. 2011, Article ID 849387, 2011.
  2. Panosyan EH, Ikeda AK, Chang V, Laks DR, Reeb CL Bowles L, Lasky III JL, Moore TB. High Dose Chemotherapy with Autologous Hematopoietic Stem Cell Rescue (AHSCR) for Pediatric Brain Tumor Patients. Journal of Transplantation. vol 2011:740673, 2011
  3. Fung AO, Damoiseaux R, Grundeen S, Pannes J, Horton DH, Judy JW, Moore TB. Quantitative Detection of PfHRP2 in Saliva of Malaria Patients in the Philippines. Malaria Journal 11:175, 2012.
  4. Kamani NR, Walters M, Carter S, Aquino V, Brochstein J, Chauhury S, Eapen M, Freed B, Grimley M, Levine J, Logan B, Moore TB, Panpinto J, Parikh S, Pulsipher M, Sande J, Schultz KR, Spellman S, Shenoy S. Unrelated Donor Cord blood Transplantation for Children with Severe Sickle Cell Disease: Results of a Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Biology of Blood and Marrow Transplantation 18:1265-1272, 2012.
  5. Fung AO, Damoiseaux R, Grundeen S, Pannes J, Horton DH, Judy JW, Moore TB. Quantitative Detection of PfHRP2 in Saliva of Malaria Patients in the Philippines. Malaria Journal 11:175, 2012.
  6. Kamani NR, Walters M, Carter S, Aquino V, Brochstein J, Chauhury S, Eapen M, Freed B, Grimley M, Levine J, Logan B, Moore TB, Panpinto J, Parikh S, Pulsipher M, Sande J, Schultz KR, Spellman S, Shenoy S. Unrelated Donor Cord blood Transplantation for Children with Severe Sickle Cell Disease: Results of a Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Biology of Blood and Marrow Transplantation 18:1265-1272, 2012.
  7. Chan WY, Roberts RL, Moore TB, Stiehm ER. Cord blood transplants for SCID: better B-cell engraftment? Journal of Pediatric Hematology/Oncology, 35(1):14-8, 2013.
  8. Venkatramani R, Lasky J, Haley K, Gilles F, Sposto R, Ji L, Olshefski R, Garvin J, Tekautz T, Kennedy G, Rassekh R, Moore TB, Gardner S, Allen J, Shore R, Moertel C, Atlas M, Dhall G, Finlay J. Outcome of Infants and Young Children with Newly Diagnosed Ependymoma Treated on the “Head Start” III Prospective Clinical Trial. J. Neuro-Oncology , 113 (2):285-291, 2013.
  9. Kuo C, Chase J, Garcia-Lloret M, Stiehm ER, Moore TB, Aguilera MJ, Siles JL, Church J. Newborn Screening for Severe Combined Immunodeficiency Does Not Identify Bare Lymphocyte Syndrome. Journal of Allergy and Clinical Immunology 131(6):1693-5, 2013.
  10. Mitton B, Oliveira SN, Pullarkat ST, Moore TB. Stem Cell Transplantation in Primary Myelofibrosis of Childhood. Journal of Pediatric Hematology/Oncology, 35(3):E120-122, 2013.
  11. Buchbinder D, Margolis D, Moore TB, Nugent D. Successful Autologous Cord Blood Transplantation in a child with Acquired Severe Aplastic Anemia. Pediatric Blood and Cancer. 17(3):E104-7, 2013.
  12. Lasky JL, Panosyan EH, Prins RM, Plant A, Davidson T, Liau LM, Moore TB. Autologous Tumor Lysate-pulsed Dendritic Cell Immunotherapy for Pediatric Patients with Primary or Recurrent High-Grade Gliomas. Anticancer Research, 33(5):2047-56, 2013.
  13. Kwan A, Church JA, Cowan M, Agarwal R, Kapoor N, Kohn D, Lewis D, Moore TB, Stiehm ER, Porteus M, McGhee SA, Bhandal A, Aznar CP, Lorey F, Puck JM. Improved outcomes through newborn screening: California's SCID experience. Journal of Allergy and Clinical Immunology 132(1):140-50, 2013.
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Theodore Bruce Moore,  click here to update your profile.